Around 900 adults with advanced Parkinson’s are set to benefit from new treatment after NICE approved it for NHS. NICE has recommended foslevodopa–foscarbidopa (also called Produodopa and made by AbbVie) as an option for treating advanced Parkinson’s, a progressive disorder that affects the nervous system and the parts of the body controlled by the nerves.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.
Networks can be open to all or available only to a closed group defined by the administrator.
Join or create a network here.
